BioCryst Pharmaceuticals BCRX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from BioCryst Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's operating margin?
- BioCryst Pharmaceuticals (BCRX) reported operating margin of -43.1% in Q1 2026.
- How has BioCryst Pharmaceuticals's operating margin changed year-over-year?
- BioCryst Pharmaceuticals's operating margin decreased by 754.3% year-over-year, from 6.6% to -43.1%.
- What is the long-term trend for BioCryst Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's operating margin has grown at a -47.5% compound annual growth rate (CAGR), from -981.1% to 39%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.